Nusantara Diet (Low Calorie and Low Sodium) for Metabolic Syndrome
Nusantara Diet (Balance Nutrition With Low Calorie and Low Sodium Diet) Impact on Body Composition, Insulin Resistance, and Lipid Profile in Patients With Risk of Metabolic Syndrome
1 other identifier
interventional
50
1 country
1
Brief Summary
The goal of this randomized clinical trial is to evaluate the effect of Nusantara Diet (Low Calorie and Low Sodium) for Metabolic Syndrome. The main questions it aims to answer are:
- How effective the Nusantara diet in reducing body mass index and body fat percentage?
- How effective the Nusantara diet in affecting lipid profile and insulin resistance? Participants will be given this diet for a period of 56 days and undergo repeated outcome measurement. This study has a comparison group (no intervention) to see the difference of reduction or slope of changes in outcomes. We assumed that the Nusantara diet will reduce the metabolic syndrome indicators (anthropometry, lipid profile, and insulin resistance profile).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 15, 2022
CompletedFirst Submitted
Initial submission to the registry
September 30, 2022
CompletedFirst Posted
Study publicly available on registry
October 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2023
CompletedOctober 4, 2022
September 1, 2022
6 months
September 30, 2022
September 30, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Body Mass Index
Defined as body weight in kilogram defined by square of body height in meter. Higher number indicates obesity
changes of body mass index from baseline to day 56
Lipid profile
parameters of lipid (total cholesterol, LDL, HDL, Triglyceride) measured from blood sample
changes of lipid profile from baseline to day 56
Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
HOMA-IR was calculated according to the formula: fasting insulin x fasting glucose/22.5.
changes of HOMA-IR from baseline to day 56
Body Fat Percentage
Body Fat Percentage is the total mass of fat divided by total body mass, multiplied by 100. This is measured by Bioelectrical Impedance Analyzer.
changes of Body Fat Percentage from baseline to day 56
Study Arms (2)
Intervention
EXPERIMENTALThis group will receive dietary adjustment and nutrition counseling.
Control
ACTIVE COMPARATORThis group will receive standard diet and nutrition counseling.
Interventions
Diet Nusantara consists of 1700 kilocalories (or 500 kilocalories lower than basal energy expenditure) on first month and subsequent reduction for the following months (200 kilocalories). The participants should also limit the sodium intake not more than 2300 mg daily
Nutrition counseling consists of the definition of balancing food, metabolic syndrome, exercise, and related health parameters.
Eligibility Criteria
You may qualify if:
- Fulfill the definition of metabolic syndrome
- Blood Pressure\>135/85 mmHg
- Central obesity with waist circumference for males\>90 cm or \>80 cm in females
- Triglyceride level \>150 mg/dL, followed by HDL\<40 mg/dL
- blood fasting glucose \>100 mg/dL
You may not qualify if:
- pregnant or breastfeeding women
- suffer from chronic disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wahidin Sudirohusodo General Hospital
Makassar, South Sulawesi, 76124, Indonesia
Related Publications (8)
Sigit FS, Tahapary DL, Trompet S, Sartono E, Willems van Dijk K, Rosendaal FR, de Mutsert R. The prevalence of metabolic syndrome and its association with body fat distribution in middle-aged individuals from Indonesia and the Netherlands: a cross-sectional analysis of two population-based studies. Diabetol Metab Syndr. 2020 Jan 7;12:2. doi: 10.1186/s13098-019-0503-1. eCollection 2020.
PMID: 31921359BACKGROUNDRochlani Y, Pothineni NV, Kovelamudi S, Mehta JL. Metabolic syndrome: pathophysiology, management, and modulation by natural compounds. Ther Adv Cardiovasc Dis. 2017 Aug;11(8):215-225. doi: 10.1177/1753944717711379. Epub 2017 Jun 22.
PMID: 28639538BACKGROUNDPapamandjaris AA, MacDougall DE, Jones PJ. Medium chain fatty acid metabolism and energy expenditure: obesity treatment implications. Life Sci. 1998;62(14):1203-15. doi: 10.1016/s0024-3205(97)01143-0.
PMID: 9570335BACKGROUNDLipoeto NI, Agus Z, Oenzil F, Wahlqvist M, Wattanapenpaiboon N. Dietary intake and the risk of coronary heart disease among the coconut-consuming Minangkabau in West Sumatra, Indonesia. Asia Pac J Clin Nutr. 2004;13(4):377-84.
PMID: 15563444BACKGROUNDde la Iglesia R, Loria-Kohen V, Zulet MA, Martinez JA, Reglero G, Ramirez de Molina A. Dietary Strategies Implicated in the Prevention and Treatment of Metabolic Syndrome. Int J Mol Sci. 2016 Nov 10;17(11):1877. doi: 10.3390/ijms17111877.
PMID: 27834920BACKGROUNDGoossens GH. The Metabolic Phenotype in Obesity: Fat Mass, Body Fat Distribution, and Adipose Tissue Function. Obes Facts. 2017;10(3):207-215. doi: 10.1159/000471488. Epub 2017 Jun 1.
PMID: 28564650BACKGROUNDDi Daniele N, Noce A, Vidiri MF, Moriconi E, Marrone G, Annicchiarico-Petruzzelli M, D'Urso G, Tesauro M, Rovella V, De Lorenzo A. Impact of Mediterranean diet on metabolic syndrome, cancer and longevity. Oncotarget. 2017 Jan 31;8(5):8947-8979. doi: 10.18632/oncotarget.13553.
PMID: 27894098BACKGROUNDGusnedi, Abdullah M, Witjaksono F, Mansyur M, Nurwidya F, Djuwita R, Dwiriani CM, Fahmida U. Promotion of optimized food-based recommendations to improve dietary practices and nutrient intakes among Minangkabau women of reproductive age with dyslipidemia. Asia Pac J Clin Nutr. 2020;29(2):334-347. doi: 10.6133/apjcn.202007_29(2).0016.
PMID: 32674241BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Agussalim Bukhari, MD.Phd
Hasanuddin University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- masking is not feasible according to the study design.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Lecturer
Study Record Dates
First Submitted
September 30, 2022
First Posted
October 4, 2022
Study Start
July 15, 2022
Primary Completion
December 30, 2022
Study Completion
February 1, 2023
Last Updated
October 4, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share
De-identified data in a form of publication supplement will be shared accordingly